Home
Bristol Myers Squibb BMY spent $2.1M on lobbying in Q4 2023 · Health Issues, Medicare and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $2,060,000
- Quarter
- Q4 2023
- Reported
- 24/01/21
Down 5.5% from last quarter
What else happened in Bristol Myers Squibb around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Bristol-Myers Squibb Company's other lobbying reports
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$50K
$50K
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$80K
$80K
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$3.2M
$3.2M
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
Under $5,000
Under $5,000
Reported 07/20
for Q2
- Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
LobbyingBristol Myers Squibb
BMY
$60K
$60K
Reported 07/20
for Q2